New York, NY -- (SBWIRE) -- 12/26/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: C.H. Robinson Worldwide, Inc (NASDAQ:CHRW), Hologic, Inc (NASDAQ:HOLX), Maxim Integrated Products Inc (NASDAQ:MXIM), Acxiom Corporation (NASDAQ:ACXM)
C.H. Robinson Worldwide, Inc (NASDAQ:CHRW) showed a volume of 999,549.00 shares by the end of last trade whereas the average volume of the stock remained 2.01 million shares. The stock opened the session at $57.22 but then moved to $57.04. C.H. Robinson Worldwide, Inc. (C.H. Robinson) is a third party logistics company. The Company provides freight transportation services and logistics solutions to companies of all sizes, in a range of industries. The Company operates through a network of 276 offices, which the Company calls branches, in North America, Europe, Asia, South America, and Australia. The Company has developed global transportation and distribution networks to provide transportation and supply chain services worldwide. In addition to transportation, the Company provides sourcing services (Sourcing).
Is CHRW a Solid Investment at These Levels? Read This Report For Details
Hologic, Inc (NASDAQ:HOLX) opened the session at $22.53 and closed the session at $22.57. The stock showed a positive performance of 0.13% in previous trading session. Traded with volume of 987,749.00 shares in the prior session and the average volume of the stock remained 6.28 million shares. Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women. The Company operates in four segments: Breast Health, Diagnostics, GYN Surgical and Skeletal Health. The Company sells and services its products through a combination of direct sales and service forces and a network of independent distributors and sales representatives. On August 1, 2012, the Company acquired Gen-Probe Incorporated (Gen-Probe). Gen-Probe is engaged in molecular diagnostics products and services,
For How Long HOLX will fight for Profitability? Read This Trend Analysis report
Maxim Integrated Products Inc (NASDAQ:MXIM) opened the session at $28.29and closed the session at $28.31. The stock showed a positive performance of 0.39% in previous trading session. Traded with volume of 986,357.00 shares in the prior session and the average volume of the stock remained 2.72 million shares. The beta of the stock remained 0.89. Maxim Integrated Products, Inc. (Maxim) designs, develops, manufactures and markets a range of linear and mixed-signal integrated circuits, commonly referred to as analog circuits, for a number of customers in diverse geographical locations. The end-markets in which the Company sells its products are the industrial, communications, consumer and computing markets. The Company utilizes its own wafer fabrication facilities as well as third party foundries for the production of its wafers.
Why Should Investors Buy MXIM After The Recent Gain? Just Go Here and Find Out
Acxiom Corporation (NASDAQ:ACXM) the stock decreased -0.49% and finished the session at $36.83. Traded with volume of 982,226.00 shares in the prior session and the average volume of the stock remained 507,755.00 shares. The beta of the stock remained 1.17. Acxiom Corporation (Acxiom) is an enterprise data, analytics and software-as-a-service company. The Company operates in three segments: Marketing and Data Services, IT Infrastructure Management, and Other Services. The Marketing and Data Services segment includes its global lines of business for customer data integration, consumer insight solutions, marketing management services,
Will ACXM Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)